Sabra Healthcare Ownership

SBRA Stock  USD 18.52  0.11  0.60%   
Sabra Healthcare REIT shows a total of 236.59 Million outstanding shares. The majority of Sabra Healthcare REIT outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Sabra Healthcare to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Sabra Healthcare REIT. Please pay attention to any change in the institutional holdings of Sabra Healthcare REIT as this could imply that something significant has changed or is about to change at the company. Also note that roughly one million sixty-four thousand six hundred fourty-two invesors are currently shorting Sabra Healthcare expressing very little confidence in its future performance.
 
Shares in Circulation  
First Issued
2009-03-31
Previous Quarter
234 M
Current Value
237 M
Avarage Shares Outstanding
115.8 M
Quarterly Volatility
86.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Sabra Healthcare in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Sabra Healthcare, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividend Payout Ratio is expected to grow to 21.18, whereas Dividends Paid is forecasted to decline to about 202.1 M. As of November 25, 2024, Common Stock Shares Outstanding is expected to decline to about 131.1 M. The current year's Net Loss is expected to grow to about (66.4 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Sabra Stock Ownership Analysis

About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.59. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sabra Healthcare REIT last dividend was issued on the 15th of November 2024. The entity had 1:3 split on the 16th of November 2010. As of March 31, 2022, Sabras investment portfolio included 416 real estate properties held for investment. As of March 31, 2022, Sabras real estate properties held for investment included 41,445 bedsunits, spread across the United States and Canada. Sabra REIT operates under REITHealthcare Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 42 people. To find out more about Sabra Healthcare REIT contact Richard Matros at 888 393 8248 or learn more at https://www.sabrahealth.com.
Besides selling stocks to institutional investors, Sabra Healthcare also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Sabra Healthcare's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Sabra Healthcare's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Sabra Healthcare Quarterly Liabilities And Stockholders Equity

5.37 Billion

Sabra Healthcare Insider Trades History

Only 1.16% of Sabra Healthcare REIT are currently held by insiders. Unlike Sabra Healthcare's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Sabra Healthcare's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Sabra Healthcare's insider trades
 
Credit Downgrade
 
Yuan Drop
 
Covid

Sabra Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Sabra Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sabra Healthcare REIT backward and forwards among themselves. Sabra Healthcare's institutional investor refers to the entity that pools money to purchase Sabra Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Dimensional Fund Advisors, Inc.2024-09-30
3.4 M
Deutsche Bank Ag2024-06-30
3.3 M
Northern Trust Corp2024-09-30
3.3 M
Jpmorgan Chase & Co2024-06-30
3.1 M
Norges Bank2024-06-30
2.8 M
Apg Investments Us Inc2024-06-30
2.6 M
Systematic Financial Management Lp2024-09-30
2.3 M
Duff & Phelps Inv Mgmt Co (il)2024-06-30
M
Advisors Capital Management, Llc2024-09-30
1.9 M
Vanguard Group Inc2024-09-30
34.9 M
Blackrock Inc2024-06-30
34.4 M
Note, although Sabra Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sabra Healthcare REIT Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sabra Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sabra Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sabra Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Richard Matros over two months ago
Acquisition by Richard Matros of 12412 shares of Sabra Healthcare subject to Rule 16b-3
 
Foster Michael J over two months ago
Acquisition by Foster Michael J of 1011 shares of Sabra Healthcare subject to Rule 16b-3
 
Barbarosh Craig A. over three months ago
Acquisition by Barbarosh Craig A. of 9480 shares of Sabra Healthcare subject to Rule 16b-3
 
Michael Costa over three months ago
Acquisition by Michael Costa of 3004 shares of Sabra Healthcare subject to Rule 16b-3
 
Richard Matros over three months ago
Acquisition by Richard Matros of 13923 shares of Sabra Healthcare subject to Rule 16b-3
 
Cusack Catherine over six months ago
Acquisition by Cusack Catherine of 7000 shares of Sabra Healthcare at 14.43 subject to Rule 16b-3
 
Foster Michael J over six months ago
Disposition of 10000 shares by Foster Michael J of Sabra Healthcare at 14.683 subject to Rule 16b-3
 
Porter Clifton J Ii over six months ago
Acquisition by Porter Clifton J Ii of 473 shares of Sabra Healthcare subject to Rule 16b-3
 
Craig Barbarosh over six months ago
Acquisition by Craig Barbarosh of 1101 shares of Sabra Healthcare subject to Rule 16b-3
 
Porter Clifton J Ii over six months ago
Acquisition by Porter Clifton J Ii of 570 shares of Sabra Healthcare subject to Rule 16b-3
 
Michael Costa over six months ago
Disposition of 5151 shares by Michael Costa of Sabra Healthcare at 11.8 subject to Rule 16b-3
 
Richard Matros over six months ago
Acquisition by Richard Matros of 14317 shares of Sabra Healthcare subject to Rule 16b-3

Sabra Healthcare Outstanding Bonds

Sabra Healthcare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sabra Healthcare REIT uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sabra bonds can be classified according to their maturity, which is the date when Sabra Healthcare REIT has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Sabra Healthcare Corporate Filings

8K
12th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
18th of October 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
19th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
26th of April 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sabra Healthcare REIT offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sabra Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sabra Healthcare Reit Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sabra Healthcare Reit Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.111
Dividend Share
1.2
Earnings Share
0.41
Revenue Per Share
2.943
Quarterly Revenue Growth
0.107
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.